Please login to the form below

Not currently logged in
Email:
Password:

Avanir Pharmaceuticals appoints new president and CEO

Rohan Palekar succeeds Keith Katkin

US-based biopharmaceutical firm Avanir Pharmaceuticals has appointed Rohan Palekar as its new president and chief executive officer.

He will be responsible for overseeing the development of the company's pipeline of products for CNS disorders along with the commercialisation of its recently FDA-approved neurological product, Nuedexta.

Palekar joined Avanir as senior vice president and chief commercial officer in March 2012 and was promoted to executive vice president and chief operating officer three years later.

He has over 20 years of drug development and commercialisation experience, having previously worked as chief commercial officer for Medivation and in various senior management roles at Johnson & Johnson and Centocor.

Palekar replaces Keith Katkin who served as president and chief executive officer for Avanir from March 2007 and will continue on at the company as a member of its board of directors.

Katkin said: “After nearly a decade of serving as Avanir's president and chief executive officer, I am incredibly proud of what we have accomplished and how much we have grown, transitioning from a development to a commercial organisation.

“I am very pleased to be transitioning to this new role and handing the reins to Roham, a passionate and innovative leader who ... has made significant contributions since joining Avanir over three years ago.”

25th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...

Infographics